Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally. The company offers a portfolio of generic drugs for various therapeutic classes, such as cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatologicals, and anti-allergics in oral solid and liquid, external liquid, semi-solid, sterile, rectal, and specialized forms. It also provides management and treasury services. Jacobson Pharma Corporation Limited was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong.
Research context
Jacobson Pharma Corporation Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Jacobson Pharma Corporation Limited is currently in a long term downtrend where the price is trading 29.7% below its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Jacobson Pharma Corporation Limited's total revenue sank by 48.1% to $393M since the same quarter in the previous year.
Its net income has dropped by 57.6% to $54M since the same quarter in the previous year.
Finally, its free cash flow fell by 67.4% to $69M since the same quarter in the previous year.
Based on the above factors, Jacobson Pharma Corporation Limited gets an overall score of 1/5.